Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 4, 2006
has subject area
- 11 Medical and Health Sciences (FoR)
- Bone Density Conservation Agents (MeSH)
- Canada (MeSH)
- Diphosphonates (MeSH)
- Drug Interactions (MeSH)
- Female (MeSH)
- Fractures, Bone (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Osteoporosis (MeSH)
- Parathyroid Hormone (MeSH)
- Practice Guidelines as Topic (MeSH)
- Review Literature as Topic (MeSH)
- Teriparatide (MeSH)